Coulter Partners places R&D Senior Project Director at Vicore Pharma Holding
London, UK and Copenhagen, Denmark – 4 November 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Vicore Pharma Holding AB (STO: VICO) and is pleased to announce the placement of Katrine Husum as R&D Senior Project Director.
Vicore Pharma is a clinical-stage pharmaceutical company focused on developing treatments for severe respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). The company is developing a new class of drugs with disease-modifying potential.
Katrine Husum has more than 20 years of experience in the biopharmaceutical industry, specialising in project and alliance management. She has led drug development projects with global cross-functional teams and strategic partnerships across the R&D value chain. Her previous roles include Head of Project and Alliance Management at Nykode Therapeutics and various Project Director roles at Leo Pharma, Takeda and Nycomed.
Commenting on the appointment, Ahmed Mousa, Vicore Pharma’s Chief Executive Officer, said:
Identifying the right talent is essential to advancing our mission. We appreciate Coulter Partners’ partnership in understanding our needs and helping us secure a candidate whose expertise will strengthen our ability to deliver meaningful therapies for patients.
